Odylia Therapeutics
ATLANTA, GA · Medical Research
Built from IRS filings (latest Form 990: tax year 2024). Odylia Therapeutics has not reviewed or approved this page. Kindora is not affiliated with it.
Mission
ODLYIA UTILIZES A UNIQUE, NON-PROFIT MODEL TO ACCELERATE THE DEVELOPMENT OF GENE THERAPIES FOR PEOPLE WITH RARE DISEASE, CHANGING THE WAY TREATMENTS ARE BROUGHT FROM THE LAB TO THE CLINIC.
Financials (IRS Form 990)
Source: IRS Form 990, tax year 2024.
Who funds Odylia Therapeutics
$2.9M in foundation grants on record from 11 funders — matched from IRS 990 grant line items. Some matches may be approximate.
| Funder | Total given | Grants |
|---|---|---|
| Foundation Fighting Blindness | $1.5M | 2 |
| Usher 2020 Foundation | $539K | 3 |
| Marin Community Foundation | $500K | 1 |
| National Philanthropic Trust | $90K | 3 |
| Dorfman Foundation | $68K | 2 |
| Morgan Stanley Global Impact Funding Trust | $53K | 3 |
| Michael Chernow Trust Fbo Charity Ccc | $50K | 2 |
| Rdh12 Fund for Sight | $50K | 1 |
| Donor Advised Charitable Giving | $25K | 1 |
| American Online Giving Foundation | $10K | 2 |
Leadership
ASHLEY WINSLOW — CEO/CSO (Principal officer)
Names of officers and trustees come from the organization's public filings and leave this page when a later filing drops them. If you are named here and object, write to privacy@kindora.co.